Large Vessel Vasculitis After the Administration of Oxford-AstraZeneca COVID-19 Vaccine
Description
We report a case of a 52-year-old female with Large Vessel Vasculitis (LVV) after vaccination with Oxford-AstraZeneca COVID-19 vaccine. She was presented with fever, started two weeks after the second dose of vaccine. Laboratory values, revealed
